Evidence map›Paper›PMID 41248163›Full record

ArticlePloS one2025

Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework.

Ida Sperle, Nikolay Lunchenkov, Anastassiya Stepanovich-Falke, Zuridin S Nurmatov, Aybek A Bekbolotov, Aisuluu Bolotbaeva, Aman Taalaibekov, Zamira Abdrakhmanova, Zulpueva Akmaral Aidarbekovna, Michael Brandl and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ida SperleRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.ORCID https://orcid.org/0009-0000-5672-8250
Nikolay LunchenkovRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.ORCID https://orcid.org/0000-0001-8567-9240
Anastassiya Stepanovich-FalkeRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.
Zuridin S NurmatovNational Institute of Public Health of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic.
Aybek A BekbolotovNational Institute of Public Health of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic.
Aisuluu BolotbaevaIndependent consultant, Bishkek, Kyrgyz Republic.
Aman TaalaibekovNational Institute of Public Health of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic.
Zamira AbdrakhmanovaNational Institute of Public Health of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic.ORCID https://orcid.org/0000-0002-2645-863X
Zulpueva Akmaral AidarbekovnaNational Institute of Public Health of the Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyz Republic.ORCID https://orcid.org/0009-0002-2785-9811
Michael BrandlRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.ORCID https://orcid.org/0000-0003-2820-5019
Olena KysilRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.
Stela BivolWHO Regional Office for Europe, Copenhagen, Denmark.
Viviane BremerRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.
Barbara Gunsenheimer-BartmeyerRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.
Sandra DudarevaRobert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionThe Kyrgyz programme on the elimination of HIV and ending AIDS and viral hepatitis infections (2023-2027) recognizes the need to scale up testing and include primary healthcare. Our aim was to identify and analyse important barriers and facilitators to HIV and hepatitis B, C and D testing from the perspective of medical doctors working in primary healthcare in the Kyrgyz Republic.

methodsWe conducted a cross-sectional, mixed-methods study in the Kyrgyz Republic from June to November 2024, and first conducted in-depth semi-structured interviews. We applied a thematic analysis for qualitative analysis. We developed a questionnaire based on these main themes, which was distributed to medical doctors working in primary healthcare. A descriptive analysis of the questionnaire data followed.

resultsThrough 21 interviews, we identified training gaps, lack of knowledge, lack of time and physical space as well as social and cultural perceptions as key barriers. Data from 1,080 questionnaire responses (89% female; 46% 61 years or older) supported this with 35% reporting lack of time, 39% lack of doctors, and over 60% indicating need for further training. Identified facilitators included knowledge of guidelines, new technologies, e.g., self-testing, and the possibility of linking testing to hepatitis B vaccination. Questionnaire data confirmed access to free testing and treatment (HIV: 86%, viral hepatitis 89%), knowledge of testing indications (HIV: 80%, viral hepatitis: 76%), and linkage to vaccination (71%) as important facilitators. Lack of experience with key populations was evident with 78% not identifying any members of key populations as patients.

conclusionTo increase testing and reach the goals of ending AIDS and the epidemics of viral hepatitis, doctors in primary healthcare need capacity-building in the form of HIV and viral hepatitis training and knowledge dissemination to offer testing. Moreover, the availability and distribution of doctors in primary healthcare need to be prioritized and enhanced in areas in most need of care to ensure access to testing for all in the Kyrgyz Republic.

Indexed as

Hepatitis BHepatitis CHepatitis, Viral, HumanHIV InfectionsPrimary Health CareAdultCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansKyrgyzstanMaleMass ScreeningMiddle AgedSurveys and Questionnaires

Identifiers

PMID41248163
PMCPMC12622783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.